Alkaline Phosphatase and Hypophosphatasia

[1]  T. Odrljin,et al.  Asfotase alfa therapy for children with hypophosphatasia. , 2016, JCI insight.

[2]  Lisa Morris,et al.  Management of Craniosynostosis , 2016, Facial Plastic Surgery.

[3]  M. Whyte.  Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment , 2016, Nature Reviews Endocrinology.

[4]  N. Bishop,et al.  Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. , 2016, The Journal of clinical endocrinology and metabolism.

[5]  J. Millán,et al.  Alkaline Phosphatase and Hypophosphatasia , 2015, Calcified Tissue International.

[6]  J. Millán,et al.  Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia. , 2015, Bone.

[7]  D. Wenkert,et al.  Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. , 2015, Bone.

[8]  J. Millán,et al.  Pathophysiological Role of Vascular Smooth Muscle Alkaline Phosphatase in Medial Artery Calcification , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  J. Millán,et al.  Functional Significance of Calcium Binding to Tissue-Nonspecific Alkaline Phosphatase , 2015, PloS one.

[10]  J. Millán,et al.  Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. , 2015, Bone.

[11]  R. Sah,et al.  Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia , 2015, Journal of dental research.

[12]  László Négyessy,et al.  Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP) , 2015, Subcellular Biochemistry.

[13]  J. Millán,et al.  Ablation of Osteopontin Improves the Skeletal Phenotype of Phospho1−/− Mice , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Millán,et al.  Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia. , 2014 .

[15]  H. Fuchs,et al.  Erratum to: New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis , 2014, Mammalian Genome.

[16]  J. Millán,et al.  Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[17]  A. Chiang,et al.  Single‐ and Multiple‐Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  P. Ciancaglini,et al.  Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential , 2014, PloS one.

[19]  W. Lei,et al.  Alkaline phosphatases contribute to uterine receptivity, implantation, decidualization, and defense against bacterial endotoxin in hamsters. , 2013, Reproduction.

[20]  O. Levy,et al.  Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine* , 2013, The Journal of Biological Chemistry.

[21]  R. Wightman,et al.  Tissue-Nonspecific Alkaline Phosphatase Acts Redundantly with PAP and NT5E to Generate Adenosine in the Dorsal Spinal Cord , 2013, The Journal of Neuroscience.

[22]  J. Millán,et al.  In Vivo Overexpression of Tissue‐Nonspecific Alkaline Phosphatase Increases Skeletal Mineralization and Affects the Phosphorylation Status of Osteopontin , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  J. Millán,et al.  Isozyme profile and tissue-origin of alkaline phosphatases in mouse serum. , 2013, Bone.

[24]  M. McKee,et al.  Tooth root dentin mineralization defects in a mouse model of hypophosphatasia , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  M. Whyte.  Chapter 22 – Hypophosphatasia , 2013 .

[26]  J. Millán.  The Role of Phosphatases in the Initiation of Skeletal Mineralization , 2013, Calcified Tissue International.

[27]  T. Shaffer,et al.  Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy , 2012, Pediatric pulmonology.

[28]  J. Millán,et al.  Enzyme replacement prevents enamel defects in hypophosphatasia mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  László Négyessy,et al.  Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain , 2012, Cell and Tissue Research.

[30]  J. Millán,et al.  Central Role of Pyrophosphate in Acellular Cementum Formation , 2012, PloS one.

[31]  Nick Bishop,et al.  Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.

[32]  J. Millán,et al.  Successful gene therapy in utero for lethal murine hypophosphatasia. , 2012, Human gene therapy.

[33]  J. Eisman,et al.  Genetics of Bone Biology and Skeletal Disease , 2012 .

[34]  M. Laroche.  Failure of Teriparatide in Treatment of Bone Complications of Adult Hypophosphatasia , 2012, Calcified Tissue International.

[35]  D. Wenkert,et al.  Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  J. Millán,et al.  Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. , 2011, Bone.

[37]  D. Fauvert,et al.  A Molecular‐Based Estimation of the Prevalence of Hypophosphatasia in the European Population , 2011, Annals of human genetics.

[38]  J. Millán,et al.  Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase. , 2011, Human gene therapy.

[39]  Jeffrey J. Gray,et al.  Enzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia , 2011, Journal of dental research.

[40]  J. Millán,et al.  Prolonged Survival and Phenotypic Correction of Akp2−/− Hypophosphatasia Mice by Lentiviral Gene Therapy , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  M. McKee,et al.  Loss of Skeletal Mineralization by the Simultaneous Ablation of PHOSPHO1 and Alkaline Phosphatase Function: A Unified Model of the Mechanisms of Initiation of Skeletal Calcification , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  M. Välimäki,et al.  Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. , 2010, The Journal of clinical endocrinology and metabolism.

[43]  J. Millán,et al.  Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota , 2010, Gut.

[44]  M. McKee,et al.  ASARM mineralization hypothesis: A bridge to progress , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  A. Schwabegger,et al.  Incidence of perinatal complications in children with premature craniosynostosis , 2010, Journal of perinatal medicine.

[46]  P. Ebeling,et al.  Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. , 2010, The Journal of clinical endocrinology and metabolism.

[47]  P. Ciancaglini,et al.  Proteoliposomes Harboring Alkaline Phosphatase and Nucleotide Pyrophosphatase as Matrix Vesicle Biomimetics , 2010, The Journal of Biological Chemistry.

[48]  Jeffrey J. Gray,et al.  Phosphorylation‐dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  P. Ciancaglini,et al.  Kinetic Analysis of Substrate Utilization by Native and TNAP-, NPP1-, or PHOSPHO1-Deficient Matrix Vesicles , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  J. Millán,et al.  Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. , 2009, Bone.

[51]  A. Licata,et al.  Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. , 2009, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[52]  A. Freemont,et al.  Chronic Recurrent Multifocal Osteomyelitis Mimicked in Childhood Hypophosphatasia , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  E. Wolf,et al.  Generation of N‐ethyl‐N‐nitrosourea‐induced mouse mutants with deviations in plasma enzyme activities as novel organ‐specific disease models , 2009, Experimental physiology.

[54]  P. de Mazancourt,et al.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles , 2009, BMC Medical Genetics.

[55]  Kyle R. Eberlin,et al.  Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition , 2008, Proceedings of the National Academy of Sciences.

[56]  P. Camacho,et al.  Treatment of adult hypophosphatasia with teriparatide. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[57]  R. Terkeltaub,et al.  Enzyme Replacement Therapy for Murine Hypophosphatasia , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  S. Rastan,et al.  Novel Mouse Model of Autosomal Semidominant Adult Hypophosphatasia Has a Splice Site Mutation in the Tissue Nonspecific Alkaline Phosphatase Gene Akp2 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  R. Cahill,et al.  Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. , 2007, The Journal of clinical endocrinology and metabolism.

[60]  C. Sergi,et al.  Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. , 2007, Bone.

[61]  S. Mumm,et al.  Adult hypophosphatasia treated with teriparatide. , 2007, The Journal of clinical endocrinology and metabolism.

[62]  R. Terkeltaub,et al.  Elevated Skeletal Osteopontin Levels Contribute to the Hypophosphatasia Phenotype in Akp2−/− Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  J. Millán,et al.  Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. , 2006, Biochemistry.

[64]  W. Sly,et al.  Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. , 2006, Molecular genetics and metabolism.

[65]  J. Millán.  Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology , 2006 .

[66]  S. Coburn,et al.  Cementum and Dentin in Hypophosphatasia , 2005, Journal of dental research.

[67]  Brian Christensen,et al.  Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. , 2005, The Biochemical journal.

[68]  R. Terkeltaub,et al.  Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. , 2005, The American journal of pathology.

[69]  C. Greenberg,et al.  Increased plasma pyridoxal-5′-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia , 1990, Journal of Inherited Metabolic Disease.

[70]  G. Sandusky,et al.  Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose , 2004, Toxicologic pathology.

[71]  R. Terkeltaub,et al.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. , 2004, The American journal of pathology.

[72]  G. Lajoie,et al.  Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. , 2004, The Biochemical journal.

[73]  H. Anderson,et al.  Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. , 2004, The American journal of pathology.

[74]  R. Terkeltaub,et al.  Linked Deficiencies in Extracellular PPi and Osteopontin Mediate Pathologic Calcification Associated With Defective PC‐1 and ANK Expression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  J. Kurtzberg,et al.  Marrow Cell Transplantation for Infantile Hypophosphatasia , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  J. Millán,et al.  Cutaneous metabolism of vitamin B-6. , 2003, The Journal of investigative dermatology.

[77]  J. Millán,et al.  Structural Evidence of Functional Divergence in Human Alkaline Phosphatases* , 2002, The Journal of Biological Chemistry.

[78]  M. Somerman,et al.  Cementum: A Phosphate-sensitive Tissue , 2002, Journal of dental research.

[79]  R. Terkeltaub,et al.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Millán,et al.  Function Assignment to Conserved Residues in Mammalian Alkaline Phosphatases* , 2002, The Journal of Biological Chemistry.

[81]  F. Sharom,et al.  Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[82]  A. Ménez,et al.  Structural Evidence for a Functional Role of Human Tissue Nonspecific Alkaline Phosphatase in Bone Mineralization* , 2001, The Journal of Biological Chemistry.

[83]  M. Taussig,et al.  Crystal Structure of Alkaline Phosphatase from Human Placenta at 1.8 Å Resolution , 2001, The Journal of Biological Chemistry.

[84]  G. Hunter,et al.  Binding of Bone Sialoprotein, Osteopontin and Synthetic Polypeptides to Hydroxyapatite , 2001, Connective tissue research.

[85]  S. Narisawa,et al.  Abnormal vitamin B6 metabolism in alkaline phosphatase knock‐out mice causes multiple abnormalities, but not the impaired bone mineralization , 2001, The Journal of pathology.

[86]  Y. Masamune,et al.  Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. , 2001, Endocrinology.

[87]  J. Millán,et al.  Functional Characterization of Osteoblasts and Osteoclasts from Alkaline Phosphatase Knockout Mice , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[88]  R. Terkeltaub,et al.  Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[89]  C. Giachelli,et al.  Phosphorylation of Osteopontin Is Required for Inhibition of Vascular Smooth Muscle Cell Calcification* , 2000, The Journal of Biological Chemistry.

[90]  K. Ohya,et al.  Selective Drug Delivery System to Bone: Small Peptide (Asp)6 Conjugation , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[91]  J. Millán,et al.  Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  V. Everts,et al.  Root Development in Mice Lacking Functional Tissue Non-specific Alkaline Phosphatase Gene: Inhibition of Acellular Cementum Formation , 1999, Journal of dental research.

[93]  J. Jansonius,et al.  Structure, evolution and action of vitamin B6-dependent enzymes. , 1998, Current opinion in structural biology.

[94]  H. Anderson,et al.  Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. , 1997, The American journal of pathology.

[95]  J. Millán,et al.  Mammalian Alkaline Phosphatases Are Allosteric Enzymes* , 1997, The Journal of Biological Chemistry.

[96]  J. Millán,et al.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[97]  O. Nosjean,et al.  Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects. , 1997, The Biochemical journal.

[98]  T. Guilarte,et al.  Mice lacking tissue non–specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B–6 , 1995, Nature Genetics.

[99]  P. Henthorn,et al.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. , 1995, The Journal of clinical investigation.

[100]  J. Millán,et al.  Stage‐specific expression of alkaline phosphatase during neural development in the mouse , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[101]  F. A. Leone,et al.  Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. , 1994, The Biochemical journal.

[102]  M. G. Low,et al.  Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form. , 1994, The Biochemical journal.

[103]  G. Hunter,et al.  Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. , 1994, The Biochemical journal.

[104]  C. Greenberg,et al.  A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. , 1993, Genomics.

[105]  K. Takaoka,et al.  Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. , 1992, Bone and mineral.

[106]  J. Millán,et al.  Molecular mechanism of uncompetitive inhibition of human placental and germ-cell alkaline phosphatase. , 1992, The Biochemical journal.

[107]  J. Millán,et al.  Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine. , 1991, The Biochemical journal.

[108]  M. Whyte,et al.  Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. , 1990, American journal of human genetics.

[109]  A. Smyth,et al.  Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities. , 1990, Nephron.

[110]  P. Böck,et al.  Biochemical and Morphological Effects of Human Hepatic Alkaline Phosphatase in a Neonate with Hypophosphatasia , 1989, Acta paediatrica Scandinavica. Supplement.

[111]  L. N. Wu,et al.  Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. , 1988, The Journal of biological chemistry.

[112]  H. Harris,et al.  A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Millán,et al.  A putative functional domain of human placental alkaline phosphatase predicted from sequence comparisons. , 1988, The Biochemical journal.

[114]  E. McCabe,et al.  Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. , 1988, The Journal of clinical investigation.

[115]  C. Slaughter,et al.  Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[116]  W. Murphy,et al.  Management of femoral fractures and pseudofractures in adult hypophosphatasia. , 1986, The Journal of bone and joint surgery. American volume.

[117]  S. Coburn,et al.  Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. , 1985, The Journal of clinical investigation.

[118]  W. Mcalister,et al.  Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. , 1984, The Journal of pediatrics.

[119]  J. Meyer,et al.  Can biological calcification occur in the presence of pyrophosphate? , 1984, Archives of biochemistry and biophysics.

[120]  W. Mcalister,et al.  Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. , 1982, The Journal of pediatrics.

[121]  W. Murphy,et al.  Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred. , 1982, The American journal of medicine.

[122]  S. Teitelbaum,et al.  Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[123]  W. Fishman,et al.  Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred. , 1980, Clinical chemistry.

[124]  W. Murphy,et al.  Adult Hypophosphatasia: CLINICAL, LABORATORY, AND GENETIC INVESTIGATION OF A LARGE KINDRED WITH REVIEW OF THE LITERATURE , 1979, Medicine.

[125]  M. Boguski.  Subcellular Biochemistry , 1979, Springer US.

[126]  G. W. Bernard.  Ultrastructural localization of alkaline phosphatase in initial intramembranous osteogenesis. , 1978, Clinical orthopaedics and related research.

[127]  H. Fleisch,et al.  The role of inhibitors and other factors in the pathogenesis of recurrent calcium-containing renal stones. , 1977, Clinical science and molecular medicine.

[128]  R. Majeska,et al.  Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. , 1975, Biochimica et biophysica acta.

[129]  R. G. Henderson,et al.  The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets. , 1975, Clinical science and molecular medicine.

[130]  D. Morgan,et al.  Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. , 1971, The Journal of clinical investigation.

[131]  H. Pitot,et al.  The metabolism of O-phosphorylethanolamine in animal tissues. II. Metabolic regulation of O-phosphorylethanolamine phospho-lyase in vivo. , 1970, Archives of biochemistry and biophysics.

[132]  H. Anderson,et al.  Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Pitot,et al.  The metabolism of O-phosphorylethanolamine in animal tissues. I. O-phosphorylethanolamine phospho-lyase: partial purification and characterization. , 1970, The Journal of biological chemistry.

[134]  H. Pitot,et al.  O-phosphorylethanolamine ammonia lyase, a new pyridoxal phosphate-dependent enzyme. , 1969, Biochemical and biophysical research communications.

[135]  R. H. Eaton,et al.  Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. , 1967, The Biochemical journal.

[136]  H. Fleisch,et al.  Effect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium Homeostasis , 1966, Nature.

[137]  R. Russell,et al.  EXCRETION OF INORGANIC PYROPHOSPHATE IN HYPOPHOSPHATASIA. , 1965, Lancet.

[138]  J. Rathbun,et al.  Hypophosphatasia; a new developmental anomaly. , 1948, American journal of diseases of children.

[139]  E. A..  The Significance of Phosphoric Esters in Metabolism , 1933, Nature.

[140]  R. Robison.  The Possible Significance of Hexosephosphoric Esters in Ossification. , 1991, Biochemical Journal.